Skip to main content
. 2022 Oct 10;17:4725–4741. doi: 10.2147/IJN.S381170

Scheme 1.

Scheme 1

Schematic illustration of the M1/IR780@PLGA nanoparticles for antitumor SDT and subsequent converting M2 tumor-associated macrophages to the M1 type, activating dendritic cells mature and leading to a strong antitumor immunity effect.